Connect with us

International

India approves use of two locally made COVID-19 vaccines

Published

on

Health authorities in India have approved the use of two locally made COVID-19 vaccines to stem the outbreak of the second wave of the virus.

This was confirmed in a statement issued on Sunday by India’s Drugs Controller General Dr Venugopal G Somani who said that the vaccines were developed by AstraZeneca and Oxford University, in conjunction with a local pharmaceutical firm Bharat Biotech.

The Drugs Controller General Dr Venugopal also informed in the statement that both vaccines would be administered to infected patients in two doses.

READ ALSO: India records six cases of new mutant COVID-19

“The… vaccines of Serum Institute [AstraZeneca-Oxford vaccine] and Bharat Biotech are being approved for restricted use in emergency situations,” Somani said, referring to the Indian firm that manufactured the former vaccine.

According to India’s Prime Minister, Narendra Modi, the fast-track approvals were “a decisive turning point to strengthen a spirited fight” that “accelerates the road to a healthier and COVID-free nation”.

“It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India!” Modi said on Twitter, calling it a sign of a “self-reliant” country.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now